周一，BMO Capital Markets 强调了礼来公司假期前产品销售的积极前景。分析师观察到，礼来公司的糖尿病和肥胖症治疗药物 Mounjaro 和 Zepbound 的总处方量和新处方量明显上升，总处方量（TRx）分别增长了 4.5% 和 5.7%。

a DB = double-blind, DM = diabetes mellitus, HbA 1c = glycosylated hemoglobin, MC = multicenter, NPH = isophane insulin human, NR = not recorded, OL = open-label, PG = parallel-group, R = randomized.